Dr. Kolluri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Leesburg
Lansdowne, VA 20176
Education & Training
Virginia Commonwealth University School of MedicineClass of 2020, Doctor of Medicine (M.D.)
Virginia Commonwealth UniversityBachelor of Science (B.S.), Biomedical Engineering, 4.00, Summa Cum Laude, Full Tuition Merit Scholarship, 2012 - 2016
Publications & Presentations
PubMed
- 13 citationsSynergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL⁺ leukemia cells.Tri K. Nguyen, Elisa Hawkins, Akhil Kolluri, Maciej Kmieciak, Haeseong Park
Leukemia Research. 2015-01-01 - 3 citationsSynergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms.Tri Nguyen, Rebecca Parker, Elisa Hawkins, Beata Holkova, Victor Yazbeck
Oncotarget. 2017-05-09 - 1 citationsCorrection: Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occurandand proceed through multiple mechanisms.Tri Nguyen, Rebecca Parker, Elisa Hawkins, Beata Holkova, Victor Yazbeck
Oncotarget. 2019-09-03
Other Languages
- Telugu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
